BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 20357450)

  • 1. Subtype classification of hepatocellular adenoma.
    Bioulac-Sage P; Balabaud C; Zucman-Rossi J
    Dig Surg; 2010; 27(1):39-45. PubMed ID: 20357450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatocellular adenoma subtype classification using molecular markers and immunohistochemistry.
    Bioulac-Sage P; Rebouissou S; Thomas C; Blanc JF; Saric J; Sa Cunha A; Rullier A; Cubel G; Couchy G; Imbeaud S; Balabaud C; Zucman-Rossi J
    Hepatology; 2007 Sep; 46(3):740-8. PubMed ID: 17663417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genotype-phenotype correlation in hepatocellular adenoma: new classification and relationship with HCC.
    Zucman-Rossi J; Jeannot E; Nhieu JT; Scoazec JY; Guettier C; Rebouissou S; Bacq Y; Leteurtre E; Paradis V; Michalak S; Wendum D; Chiche L; Fabre M; Mellottee L; Laurent C; Partensky C; Castaing D; Zafrani ES; Laurent-Puig P; Balabaud C; Bioulac-Sage P
    Hepatology; 2006 Mar; 43(3):515-24. PubMed ID: 16496320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of a liver adenoma classification system in a tertiary referral centre: implications for clinical practice.
    van Aalten SM; Verheij J; Terkivatan T; Dwarkasing RS; de Man RA; Ijzermans JN
    J Hepatol; 2011 Jul; 55(1):120-5. PubMed ID: 21145863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatocellular adenomas in a large community population, 2000 to 2010: reclassification per current World Health Organization classification and results of long-term follow-up.
    Shafizadeh N; Genrich G; Ferrell L; Kakar S
    Hum Pathol; 2014 May; 45(5):976-83. PubMed ID: 24746201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Revisiting the pathology of resected benign hepatocellular nodules using new immunohistochemical markers.
    Bioulac-Sage P; Cubel G; Balabaud C; Zucman-Rossi J
    Semin Liver Dis; 2011 Feb; 31(1):91-103. PubMed ID: 21344354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatocellular adenoma management and phenotypic classification: the Bordeaux experience.
    Bioulac-Sage P; Laumonier H; Couchy G; Le Bail B; Sa Cunha A; Rullier A; Laurent C; Blanc JF; Cubel G; Trillaud H; Zucman-Rossi J; Balabaud C; Saric J
    Hepatology; 2009 Aug; 50(2):481-9. PubMed ID: 19585623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatocellular Adenomas: Morphology and Genomics.
    Bioulac-Sage P; Sempoux C; Balabaud C
    Gastroenterol Clin North Am; 2017 Jun; 46(2):253-272. PubMed ID: 28506364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New monoallelic (partial tandem duplication) mutation of HNF1a gene in steatotic hepatocellular adenoma.
    Sakellariou S; Morgan Y; Heaton N; Portmann B; Quaglia A; Tobal K
    Eur J Gastroenterol Hepatol; 2011 Jul; 23(7):623-7. PubMed ID: 21566527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retrospective study of hepatocellular adenomas based on the phenotypic classification system: A report from China.
    Pan J; Chen L; Fan J; Zhou J; Qin L; Tan Y; Ji Y; Huang X
    Histol Histopathol; 2014 Feb; 29(2):243-9. PubMed ID: 23939475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Interest of immunohistochemistry for the diagnosis of benign hepatocellular tumors].
    Bioulac-Sage P; Balabaud C; Zucman-Rossi J
    Ann Pathol; 2010 Dec; 30(6):439-47. PubMed ID: 21167430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene mutations in hepatocellular adenomas.
    Raft MB; Jørgensen EN; Vainer B
    Histopathology; 2015 Jun; 66(7):910-21. PubMed ID: 25195525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatocellular adenoma classification: a comparative evaluation of immunohistochemistry and targeted mutational analysis.
    Margolskee E; Bao F; de Gonzalez AK; Moreira RK; Lagana S; Sireci AN; Sepulveda AR; Remotti H; Lefkowitch JH; Salomao M
    Diagn Pathol; 2016 Mar; 11():27. PubMed ID: 26961851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatocellular adenomas: magnetic resonance imaging features as a function of molecular pathological classification.
    Laumonier H; Bioulac-Sage P; Laurent C; Zucman-Rossi J; Balabaud C; Trillaud H
    Hepatology; 2008 Sep; 48(3):808-18. PubMed ID: 18688875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatocellular adenomas: review of pathological and molecular features.
    Beaufrère A; Paradis V
    Hum Pathol; 2021 Jun; 112():128-137. PubMed ID: 33307077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular Classification of Hepatocellular Adenoma Associates With Risk Factors, Bleeding, and Malignant Transformation.
    Nault JC; Couchy G; Balabaud C; Morcrette G; Caruso S; Blanc JF; Bacq Y; Calderaro J; Paradis V; Ramos J; Scoazec JY; Gnemmi V; Sturm N; Guettier C; Fabre M; Savier E; Chiche L; Labrune P; Selves J; Wendum D; Pilati C; Laurent A; De Muret A; Le Bail B; Rebouissou S; Imbeaud S; ; Bioulac-Sage P; Letouzé E; Zucman-Rossi J
    Gastroenterology; 2017 Mar; 152(4):880-894.e6. PubMed ID: 27939373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular classification of hepatocellular adenoma in clinical practice.
    Nault JC; Paradis V; Cherqui D; Vilgrain V; Zucman-Rossi J
    J Hepatol; 2017 Nov; 67(5):1074-1083. PubMed ID: 28733222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chromosomal and genetic alterations in human hepatocellular adenomas associated with type Ia glycogen storage disease.
    Kishnani PS; Chuang TP; Bali D; Koeberl D; Austin S; Weinstein DA; Murphy E; Chen YT; Boyette K; Liu CH; Chen YT; Li LH
    Hum Mol Genet; 2009 Dec; 18(24):4781-90. PubMed ID: 19762333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular characterization of hepatocellular adenomas developed in patients with glycogen storage disease type I.
    Calderaro J; Labrune P; Morcrette G; Rebouissou S; Franco D; Prévot S; Quaglia A; Bedossa P; Libbrecht L; Terracciano L; Smit GP; Bioulac-Sage P; Zucman-Rossi J
    J Hepatol; 2013 Feb; 58(2):350-7. PubMed ID: 23046672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of hepatocyte nuclear factor 1alpha function in human hepatocellular adenomas leads to aberrant activation of signaling pathways involved in tumorigenesis.
    Pelletier L; Rebouissou S; Paris A; Rathahao-Paris E; Perdu E; Bioulac-Sage P; Imbeaud S; Zucman-Rossi J
    Hepatology; 2010 Feb; 51(2):557-66. PubMed ID: 20041408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.